[
    {
        "question_id": "999_B_1323",
        "new_question_id": "59350",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "10903",
        "notes_id_link": "1_1177",
        "theme": "Management of unstable broad-complex tachycardia in elderly patient",
        "instruction": "",
        "options": [
            "",
            "Immediate synchronised DC cardioversion",
            "IV amiodarone infusion",
            "IV adenosine bolus",
            "Urgent expert electrophysiology review",
            "IV magnesium sulphate administration",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 74-year-old woman is brought to the acute admissions unit after collapsing at home. She has a history of hypertension and heart failure with preserved ejection fraction. On arrival, she is alert but confused, with cool peripheries. Her pulse is 154 bpm and regular. Blood pressure is 86/54 mmHg. ECG confirms a broad-complex tachycardia. Oxygen saturations are 98% on room air.<br /><br />What is the most appropriate immediate management step?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "<b>Immediate synchronised DC cardioversion</b> is the correct management for this patient who presents with an unstable broad-complex tachycardia. According to the Resuscitation Council (UK) guidelines, patients with tachyarrhythmias who demonstrate adverse signs require immediate electrical cardioversion. This patient has multiple adverse signs including hypotension (BP 86/54 mmHg), confusion, and cool peripheries indicating shock. The regular broad-complex tachycardia at 154 bpm in this context is life-threatening, and delaying cardioversion could lead to cardiac arrest. The presence of heart failure further increases the urgency for immediate intervention. Synchronised DC cardioversion is the definitive treatment that will rapidly terminate the arrhythmia and restore haemodynamic stability. In unstable patients, this should be performed urgently with appropriate sedation if the patient is conscious. The procedure involves delivering a timed electrical shock that is synchronised with the R wave to avoid inducing ventricular fibrillation.<br /><br /><b>IV amiodarone infusion</b> is not the most appropriate first-line management for an unstable patient with a broad-complex tachycardia. While amiodarone is an effective antiarrhythmic medication that can be used for chemical cardioversion or rate control in broad-complex tachycardias, it has a relatively slow onset of action (15-20 minutes) and would not address the immediate haemodynamic compromise in this patient. Amiodarone would be more appropriate for stable patients with broad-complex tachycardias or as a second-line treatment after electrical cardioversion if the arrhythmia recurs.<br /><br /><b>IV adenosine bolus</b> is inappropriate in this unstable patient. Adenosine is primarily used for the diagnosis and treatment of regular narrow-complex tachycardias, particularly atrioventricular nodal re-entrant tachycardia (AVNRT). While it can be used diagnostically in broad-complex tachycardias to differentiate supraventricular tachycardia with aberrant conduction from ventricular tachycardia, it should not be used in unstable patients. Additionally, adenosine can cause transient asystole and potentially worsen hypotension, which would be dangerous in this already compromised patient.<br /><br /><b>Urgent expert electrophysiology review</b> is important but not the most appropriate immediate management step. While specialist input is valuable, particularly for complex arrhythmias or recurrent episodes, the priority in this unstable patient is to restore normal cardiac rhythm and haemodynamic stability without delay. Waiting for specialist review before intervening could lead to further deterioration and potentially cardiac arrest. Once the patient is stabilised with DC cardioversion, expert electrophysiology input would be beneficial for ongoing management and prevention strategies.<br /><br /><b>IV magnesium sulphate administration</b> would not be the most appropriate first-line treatment for this patient. While magnesium can be useful in certain arrhythmias, particularly torsades de pointes (a polymorphic ventricular tachycardia associated with QT prolongation), there is no indication in this scenario that the patient has this specific type of arrhythmia. The regular broad-complex tachycardia described is more likely to be monomorphic ventricular tachycardia or supraventricular tachycardia with aberrant conduction. Magnesium would not effectively terminate these rhythms and would delay the definitive treatment needed for this unstable patient.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 74-year-old woman is brought to the acute admissions unit after collapsing at home. She has a history of hypertension and heart failure with preserved ejection fraction. On arrival, she is alert but confused, with cool peripheries. Her pulse is 154 bpm and regular. Blood pressure is 86/54 mmHg. ECG confirms a broad-complex tachycardia. Oxygen saturations are 98% on room air.<br /><br />What is the most appropriate immediate management step?",
        "correct_answer": "1",
        "question_notes": "<b>Immediate synchronised DC cardioversion</b> is the correct management for this patient who presents with an unstable broad-complex tachycardia. According to the Resuscitation Council (UK) guidelines, patients with tachyarrhythmias who demonstrate adverse signs require immediate electrical cardioversion. This patient has multiple adverse signs including hypotension (BP 86/54 mmHg), confusion, and cool peripheries indicating shock. The regular broad-complex tachycardia at 154 bpm in this context is life-threatening, and delaying cardioversion could lead to cardiac arrest. The presence of heart failure further increases the urgency for immediate intervention. Synchronised DC cardioversion is the definitive treatment that will rapidly terminate the arrhythmia and restore haemodynamic stability. In unstable patients, this should be performed urgently with appropriate sedation if the patient is conscious. The procedure involves delivering a timed electrical shock that is synchronised with the R wave to avoid inducing ventricular fibrillation.<br /><br /><b>IV amiodarone infusion</b> is not the most appropriate first-line management for an unstable patient with a broad-complex tachycardia. While amiodarone is an effective antiarrhythmic medication that can be used for chemical cardioversion or rate control in broad-complex tachycardias, it has a relatively slow onset of action (15-20 minutes) and would not address the immediate haemodynamic compromise in this patient. Amiodarone would be more appropriate for stable patients with broad-complex tachycardias or as a second-line treatment after electrical cardioversion if the arrhythmia recurs.<br /><br /><b>IV adenosine bolus</b> is inappropriate in this unstable patient. Adenosine is primarily used for the diagnosis and treatment of regular narrow-complex tachycardias, particularly atrioventricular nodal re-entrant tachycardia (AVNRT). While it can be used diagnostically in broad-complex tachycardias to differentiate supraventricular tachycardia with aberrant conduction from ventricular tachycardia, it should not be used in unstable patients. Additionally, adenosine can cause transient asystole and potentially worsen hypotension, which would be dangerous in this already compromised patient.<br /><br /><b>Urgent expert electrophysiology review</b> is important but not the most appropriate immediate management step. While specialist input is valuable, particularly for complex arrhythmias or recurrent episodes, the priority in this unstable patient is to restore normal cardiac rhythm and haemodynamic stability without delay. Waiting for specialist review before intervening could lead to further deterioration and potentially cardiac arrest. Once the patient is stabilised with DC cardioversion, expert electrophysiology input would be beneficial for ongoing management and prevention strategies.<br /><br /><b>IV magnesium sulphate administration</b> would not be the most appropriate first-line treatment for this patient. While magnesium can be useful in certain arrhythmias, particularly torsades de pointes (a polymorphic ventricular tachycardia associated with QT prolongation), there is no indication in this scenario that the patient has this specific type of arrhythmia. The regular broad-complex tachycardia described is more likely to be monomorphic ventricular tachycardia or supraventricular tachycardia with aberrant conduction. Magnesium would not effectively terminate these rhythms and would delay the definitive treatment needed for this unstable patient.",
        "answer_order": "1",
        "answer": "1",
        "title": "Peri-arrest rhythms: tachycardia",
        "body": "The 2015 Resuscitation Council (UK) guidelines have simplified the advice given for the management of peri-arrest tachycardias. Separate algorithms for the management of broad-complex tachycardia, narrow complex tachycardia and atrial fibrillation have been replaced by one unified treatment algorithm<br /><br />Following basic ABC assessment, patients are classified as being stable or unstable according to the presence of any adverse signs:<br /><ul><li>shock: hypotension (<span class=\"concept\" data-cid=\"10903\">systolic blood pressure < 90 mmHg</span>), pallor, sweating, cold, clammy extremities, confusion or impaired consciousness</li><li>syncope</li><li>myocardial ischaemia</li><li>heart failure </li></ul><br />If any of the above <span class=\"concept\" data-cid=\"1327\">adverse signs are present then synchronised DC shocks</span> should be given. Up to <span class=\"concept\" data-cid=\"5236\">3 shocks</span> can be given; after this expert help should be sought.<br /><br />Treatment following this is given according to whether the QRS complex is narrow or broad and whether the rhythm is regular or irregular. The full treatment guidelines can be found at the Resuscitation Council website, below is a very limited summary:<br /><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd965b.png\" data-fancybox=\"gallery\" data-caption=\"\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd965.png\" alt=\"\" /></a></div></div></div><br /><h5 class='notes-heading'>Broad-complex tachycardia</h5><br />Regular<br /><ul><li>assume ventricular tachycardia (unless previously confirmed SVT with bundle branch block)</li><li>loading dose of <span class=\"concept\" data-cid=\"11312\">amiodarone</span> followed by 24 hour infusion</li></ul><br />Irregular<br /><ul><li><span class=\"concept\" data-cid=\"11313\">seek expert help</span>. Possibilities include:<ul><li><span class=\"concept\" data-cid=\"11314\">atrial fibrillation with bundle branch block</span> - the most likely cause in a stable patient</li><li>atrial fibrillation with ventricular pre-excitation</li><li>torsade de pointes</li></ul></li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg087b.png\" data-fancybox=\"gallery\" data-caption=\"Broad-complex tachycardia. It can be difficult to distinguish between ventricular tachycardia and supraventricular tachycardia with aberrant conduction (e.g. LBBB). This patient did not respond to adenosine and was cardioverted. The final presumed diagnosis was that of ventricular tachycardia secondary to severe ischaemic heart disease. - e Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg087.png\" alt=\"\" /></a></div></div></div><br /><h5 class='notes-heading'>Narrow-complex tachycardia</h5><br />Regular<br /><ul><li>vagal manoeuvres followed by IV adenosine</li><li>if the above is unsuccessful consider a diagnosis of atrial flutter and control rate (e.g. beta-blockers)</li></ul><br />Irregular<br /><ul><li>probable atrial fibrillation</li><li>if onset < 48 hr consider electrical or chemical cardioversion</li><li>rate control: beta-blockers are usually first-line unless there is a contraindication</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg076b.png\" data-fancybox=\"gallery\" data-caption=\"Atrial fibrillation with a rapid ventricular response. Rate related ischaemia resulting in ST depression in V2-4 - e Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg076.png\" alt=\"\" /></a></div></div></div>",
        "notes_hash": "61008448793e1e13a3ba9fb82ed6b169",
        "knowledge_graph_node_id_link": 0,
        "concept": "In the context of a tachyarrhythmia, a systolic BP < 90 mmHg &rarr; DC cardioversion",
        "concept_percentile": "82",
        "concept_colour": "rgb(91,255,0)",
        "number_attempts": "4540",
        "up_votes": "0",
        "down_votes": "3",
        "column_array": [
            0,
            "3962",
            "324",
            "128",
            "16",
            "110",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Resuscitation Council UK</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2051\" data-linkid=\"2051\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2051\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">29</span><button type=\"button\" style=\"\" id=\"link_dislike_2051\" data-linkid=\"2051\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2051\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">12</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.resus.org.uk/sites/default/files/2021-04/Tachycardia%20Algorithm%202021.pdf\">2021 Tachycardia algorithm</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/NULY6Ecj6gA\" data-description=\"Intro to EKG Interpretation - Practicing Tachyarrhythmia Identification\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"377\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/NULY6Ecj6gA/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/NULY6Ecj6gA\" data-description=\"Intro to EKG Interpretation - Practicing Tachyarrhythmia Identification\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"377\">Intro to EKG Interpretation - Practicing Tachyarrhythmia Identification</a></td></tr><tr><td><span ><small>Strong Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_636\" data-mediaid=\"636\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_636\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_636\" data-mediaid=\"636\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_636\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/RuxKTCv_s0M\" data-description=\"Arrhythmia Overview - Mechanism of bradyarrhythmia and tachyarrhythmia\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"1089\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/RuxKTCv_s0M/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/RuxKTCv_s0M\" data-description=\"Arrhythmia Overview - Mechanism of bradyarrhythmia and tachyarrhythmia\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"1089\">Arrhythmia Overview - Mechanism of bradyarrhythmia and tachyarrhythmia</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1891\" data-mediaid=\"1891\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1891\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_1891\" data-mediaid=\"1891\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1891\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/pd5FF8jGR78\" data-description=\"Intro to EKG Interpretation - How to Identify Any Tachyarrhythmia with 6 Easy Questions\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"376\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/pd5FF8jGR78/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/pd5FF8jGR78\" data-description=\"Intro to EKG Interpretation - How to Identify Any Tachyarrhythmia with 6 Easy Questions\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"376\">Intro to EKG Interpretation - How to Identify Any Tachyarrhythmia with 6 Easy Questions</a></td></tr><tr><td><span ><small>Strong Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_635\" data-mediaid=\"635\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_635\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_635\" data-mediaid=\"635\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_635\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/iT3cVVK74tU\" data-description=\"Intro to EKG Interpretation - Overview of Tachyarrhythmias\" data-upvotes=\"7\" data-downvotes=\"2\" data-media=\"375\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/iT3cVVK74tU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/iT3cVVK74tU\" data-description=\"Intro to EKG Interpretation - Overview of Tachyarrhythmias\" data-upvotes=\"7\" data-downvotes=\"2\" data-media=\"375\">Intro to EKG Interpretation - Overview of Tachyarrhythmias</a></td></tr><tr><td><span ><small>Strong Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_634\" data-mediaid=\"634\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_634\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"media_dislike_634\" data-mediaid=\"634\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_634\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/sTdV8xCNbBM\" data-description=\"Intro to EKG Interpretation - Mechanisms of Tachyarrhythmias\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"374\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/sTdV8xCNbBM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/sTdV8xCNbBM\" data-description=\"Intro to EKG Interpretation - Mechanisms of Tachyarrhythmias\" data-upvotes=\"2\" data-downvotes=\"2\" data-media=\"374\">Intro to EKG Interpretation - Mechanisms of Tachyarrhythmias</a></td></tr><tr><td><span ><small>Strong Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_633\" data-mediaid=\"633\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_633\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_633\" data-mediaid=\"633\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_633\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 0,
        "concepts_for_notes": {
            "5236": {
                "concept_text": "Patients with tachycardia and signs of shock, syncope, myocardial ischaemia or heart failure should receive up to 3 synchronised DC shocks",
                "concept_percentile": "80"
            },
            "10903": {
                "concept_text": "In the context of a tachyarrhythmia, a systolic BP < 90 mmHg --> DC cardioversion",
                "concept_percentile": "82"
            },
            "11312": {
                "concept_text": "IV amiodarone is the first-line treatment for regular broad complex tachycardias without adverse features",
                "concept_percentile": "94"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_2260",
        "new_question_id": "2917",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "0",
        "notes_id_link": "1_1469",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Implantable progestogen",
            "Combined contraceptive pill",
            "Progestogen only pill",
            "Mirena coil (levonorgestrel releasing intrauterine device)",
            "Depo- Provera (injectable progestogen)",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 25-year-old female delivered her first child via caesarean section 4 weeks ago. She is exclusively breastfeeding and wishes to start using contraception. Which form of contraception is absolutely contraindicated?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "The answer here is the combined contraceptive pill. According to the UKMEC guidelines produced by the Faculty of Sexual and Reproductive Health, use of the combined contraceptive pill as contraception at less than 6 weeks postpartum if breastfeeding is classified as an unacceptable risk (UKMEC Cat 4). If this patient had other risk factors for venous thromboembolism and was not breastfeeding, the risks would still be deemed higher than the benefits of using this method of contraception. All of the other options would be feasible to use for contraception for this patient.<br />",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 25-year-old female delivered her first child via caesarean section 4 weeks ago. She is exclusively breastfeeding and wishes to start using contraception. Which form of contraception is absolutely contraindicated?",
        "correct_answer": "2",
        "question_notes": "The answer here is the combined contraceptive pill. According to the UKMEC guidelines produced by the Faculty of Sexual and Reproductive Health, use of the combined contraceptive pill as contraception at less than 6 weeks postpartum if breastfeeding is classified as an unacceptable risk (UKMEC Cat 4). If this patient had other risk factors for venous thromboembolism and was not breastfeeding, the risks would still be deemed higher than the benefits of using this method of contraception. All of the other options would be feasible to use for contraception for this patient.<br />",
        "answer_order": "2",
        "answer": "2",
        "title": "Postpartum contraception",
        "body": "After giving birth, women require contraception after <span class=\"concept\" data-cid=\"11416\">day 21</span>.<br /><br />Progestogen-only pill (POP)<br /><ul><li>the FSRH advise 'postpartum women (breastfeeding and non-breastfeeding) can <span class=\"concept\" data-cid=\"11489\">start the POP at any time postpartum</span>.'</li><li>after day 21 additional contraception should be used for the first 2 days</li><li>a small amount of progestogen enters breast milk but this is not harmful to the infant</li></ul><br />Combined oral contraceptive pill (COCP)<br /><ul><li>absolutely contraindicated - UKMEC 4 - if breastfeeding < 6 weeks post-partum</li><li><span class=\"concept\" data-cid=\"4290\">UKMEC 2 - if breastfeeding 6 weeks - 6 months postpartum</span>*</li><li>the COCP may reduce breast milk production in lactating mothers</li><li><span class=\"concept\" data-cid=\"11490\">should not be used in the first 21 days</span> due to the increased venous thromboembolism risk post-partum</li><li>after day 21 additional contraception should be used for the first 7 days</li></ul><br />The intrauterine device or intrauterine system can be inserted within <span class=\"concept\" data-cid=\"7870\">48 hours of childbirth or after 4 weeks</span>.<br /><br />Lactational amenorrhoea method (LAM)<br /><ul><li><span class=\"concept\" data-cid=\"4288\">is 98% effective providing the woman is fully breast-feeding (no supplementary feeds), amenorrhoeic and < 6 months post-partum</span></li></ul><br />An <span class=\"concept\" data-cid=\"8104\">inter-pregnancy interval of less than 12 months</span> between childbirth and conceiving again is associated with an increased risk of preterm birth, low birth weight and small for gestational age babies.<br /><br />*this changed from UKMEC 3 in 2016",
        "notes_hash": "936478076b7bf4d007fb91660d375fce",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5428",
        "up_votes": "28",
        "down_votes": "4",
        "column_array": [
            0,
            "61",
            "4404",
            "248",
            "373",
            "342",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Faculty of Sexual and Reproductive Health</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_680\" data-linkid=\"680\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_680\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"link_dislike_680\" data-linkid=\"680\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_680\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.fsrh.org/documents/contraception-after-pregnancy-guideline-january-2017/\">2017 Contraception After Pregnancy</a></td></tr></table><br><br><table style='width:100%'><tr><td>GP Infant Feeding Network</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1292\" data-linkid=\"1292\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1292\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"link_dislike_1292\" data-linkid=\"1292\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1292\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://gpifn.org.uk/family-planning/\">Family planning in the post-partum period</a></td></tr></table>",
        "media": "",
        "comment_count": 5,
        "concepts_for_notes": {
            "11416": {
                "concept_text": "Post-partum, women only require contraception 21 days from giving birth",
                "concept_percentile": "97"
            },
            "11489": {
                "concept_text": "Postpartum women (breastfeeding and non-breastfeeding) can start the progestogen-only pill at any time postpartum ",
                "concept_percentile": "86"
            },
            "11490": {
                "concept_text": "The COCP should not be used in the first 21 days due to the increased venous thromboembolism risk post-partum",
                "concept_percentile": "97"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "901_B_3588",
        "new_question_id": "1393",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_1147",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Weber: sound localises to the left; Rinne: BC > AC on the right and AC > BC on the left",
            "Weber: sound localises to the right; Rinne: BC > AC on the right and AC > BC on the left",
            "Weber: sound localises to the right; Rinne: AC > BC on the right and AC > BC on the left",
            "Weber: sound localises to the left; Rinne: AC > BC on the right and AC > BC on the left",
            "Weber: sound is heard centrally; Rinne: BC > AC on the right and AC > BC on the left",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "You see a 40-year-old man with reduced hearing on the right side. You examine his ears and note the right ear canal is blocked with wax but the left ear is clear. What would be the expected findings on testing Rinne and Weber?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "The Rinne and Weber tests are used to distinguish conductive from sensorineural hearing loss. <br /><br />This gentleman has wax blocking the right ear canal, so you would expect to find a conductive hearing loss on the right side. <br /><br />When performing the Weber test, the patient should localise the sound to the side of a conductive hearing loss, as bone conduction is increased. The sound will localise away from a sensorineural hearing loss. <br /><br />The Rinne test is negative if there is a conductive hearing loss, as bone conduction is better than air conduction. It is positive if air conduction is better than bone conduction, which can be the case for mild-moderate sensorineural hearing loss or if there is normal hearing. <br /><br />In this case, the wax causes a conductive hearing loss on the right side, so when performing the Weber test sound should localise to the right, and Rinne should be negative on the right side and positive on the left.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "You see a 40-year-old man with reduced hearing on the right side. You examine his ears and note the right ear canal is blocked with wax but the left ear is clear. What would be the expected findings on testing Rinne and Weber?",
        "correct_answer": "2",
        "question_notes": "The Rinne and Weber tests are used to distinguish conductive from sensorineural hearing loss. <br /><br />This gentleman has wax blocking the right ear canal, so you would expect to find a conductive hearing loss on the right side. <br /><br />When performing the Weber test, the patient should localise the sound to the side of a conductive hearing loss, as bone conduction is increased. The sound will localise away from a sensorineural hearing loss. <br /><br />The Rinne test is negative if there is a conductive hearing loss, as bone conduction is better than air conduction. It is positive if air conduction is better than bone conduction, which can be the case for mild-moderate sensorineural hearing loss or if there is normal hearing. <br /><br />In this case, the wax causes a conductive hearing loss on the right side, so when performing the Weber test sound should localise to the right, and Rinne should be negative on the right side and positive on the left.",
        "answer_order": "2",
        "answer": "2",
        "title": "Rinne's and Weber's test",
        "body": "Performing both Rinne's and Weber's test allows differentiation of conductive and sensorineural deafness.<br /><br />Rinne's test<br /><ul><li>tuning fork is placed over the mastoid process until the sound is no longer heard, followed by repositioning just over external acoustic meatus</li><li>'positive test': air conduction (AC) is normally better than bone conduction (BC)</li><li><span class=\"concept\" data-cid=\"10282\">'negative test': if BC > AC then conductive deafness</span></li></ul><br />Weber's test<br /><ul><li>tuning fork is placed in the middle of the forehead equidistant from the patient's ears</li><li>the patient is then asked which side is loudest</li><li>in unilateral sensorineural deafness, sound is localised to the unaffected side</li><li>in unilateral conductive deafness, sound is localised to the affected side</li></ul><br /><h6 class='notes-subheading'>Interpretation of Rinne and Weber tests</h6><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th></th><th>Rinne result</th><th>Weber result</th></tr></thead><tbody><tr><td><span class=\"concept\" data-cid=\"11376\"><b>Normal </b></span></td><td>Air conduction > bone conduction bilaterally</td><td>Midline</td></tr><tr><td><span class=\"concept\" data-cid=\"11375\"><b>Conductive hearing loss</b></span></td><td>Bone conduction > air conduction in affected ear<br />Air conduction > bone conduction in unaffected ear</td><td>Lateralises to affected ear</td></tr><tr><td><span class=\"concept\" data-cid=\"11374\"><b>Sensorineural hearing loss</b></span></td><td>Air conduction > bone conduction bilaterally</td><td>Lateralises to unaffected ear</td></tr></tbody></table></div>",
        "notes_hash": "8c1fb1ba2bc4f90b3be9861f7c577ac2",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6857",
        "up_votes": "22",
        "down_votes": "6",
        "column_array": [
            0,
            "1117",
            "4695",
            "223",
            "165",
            "657",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>ENT SHO</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_193\" data-linkid=\"193\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_193\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">23</span><button type=\"button\" style=\"\" id=\"link_dislike_193\" data-linkid=\"193\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_193\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">19</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://entsho.com/ear-examination\">Guide to the ear examination</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/cZYJL9Jg-3k\" data-description=\"Weber vs. Rinne Test & Conductive vs. Sensorineural Hearing Loss\" data-upvotes=\"47\" data-downvotes=\"1\" data-media=\"758\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/cZYJL9Jg-3k/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/cZYJL9Jg-3k\" data-description=\"Weber vs. Rinne Test & Conductive vs. Sensorineural Hearing Loss\" data-upvotes=\"47\" data-downvotes=\"1\" data-media=\"758\">Weber vs. Rinne Test & Conductive vs. Sensorineural Hearing Loss</a></td></tr><tr><td><span ><small>DirtyUSMLE - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1325\" data-mediaid=\"1325\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1325\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">47</span><button type=\"button\" style=\"\" id=\"media_dislike_1325\" data-mediaid=\"1325\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1325\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/_kUy4p87_nk\" data-description=\"Understanding the Causes of Hearing Loss\" data-upvotes=\"6\" data-downvotes=\"1\" data-media=\"1447\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/_kUy4p87_nk/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/_kUy4p87_nk\" data-description=\"Understanding the Causes of Hearing Loss\" data-upvotes=\"6\" data-downvotes=\"1\" data-media=\"1447\">Understanding the Causes of Hearing Loss</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2556\" data-mediaid=\"2556\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2556\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_2556\" data-mediaid=\"2556\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2556\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "11374": {
                "concept_text": "Sensorineural hearing loss\n   - Rinne result: Air conduction > bone conduction bilaterally\n   - Weber result: Lateralises to unaffected ear",
                "concept_percentile": "25"
            },
            "11375": {
                "concept_text": "Conductive hearing loss\n   - Rinne result: Bone conduction > air conduction in affected ear, Air conduction > bone conduction in unaffected ear\n   - Weber result: Lateralises to affected ear",
                "concept_percentile": "22"
            },
            "11376": {
                "concept_text": "Normal hearing\n   - Rinne result: Air conduction > bone conduction bilaterally\n   - Weber result: same in both ears",
                "concept_percentile": "1"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_E_92",
        "new_question_id": "4631",
        "question_type": "1",
        "category": "6",
        "concept_id_link": "0",
        "notes_id_link": "1_1787",
        "theme": "Hip pain in adults",
        "instruction": "For each one of the following scenarios please select the most likely diagnosis:",
        "options": [
            "",
            "Inflammatory arthritis",
            "Trochanteric bursitis",
            "Pubic symphysis dysfunction",
            "Osteoarthritis",
            "Meralgia paraesthetica",
            "Avascular necrosis",
            "Transient idiopathic osteoporosis",
            "Referred lumbar spine pain",
            "Perthes' disease",
            "Slipped upper femoral epiphysis"
        ],
        "num_of_options": 10,
        "questions": [
            "A 62-year-old man complains of pain in his right hip which is worse when he walks. Heberden's nodes are noted on examination of the distal interphalangeal joints",
            "Y 34-wcyp-mjb kyl ugrf y fgqrmpw md sjacpyrgtc amjgrgq amknjyglq md nygl ylb qrgddlcqq gl fgq jcdr fgn ufgaf gq umpqc gl rfc kmplgleq",
            "Y 29-wcyp-mjb kyl ufm gq y iccl hmeecp amknjyglq md nygl ml rfc jyrcpyj yqncar md fgq jcdr fgn. Ml cvykglyrgml rfcpc gq y dsjj pylec md kmtckclr zsr rclbcplcqq gq lmrcb ml rfc ylrcpmjyrcpyj yqncar md rfc hmglr"
        ],
        "answers": [
            "4",
            "1",
            "2"
        ],
        "notes": [
            "",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 62-year-old man complains of pain in his right hip which is worse when he walks. Heberden's nodes are noted on examination of the distal interphalangeal joints",
        "correct_answer": "4",
        "question_notes": "",
        "answer_order": "4",
        "answer": "4",
        "title": "Hip pain in adults",
        "body": "The table below provides a brief summary of the potential causes of hip pain in adults<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Condition</th><th>Features</th></tr></thead><tbody><tr><td><b>Osteoarthritis</b></td><td>Pain exacerbated by exercise and relieved by rest<br />Reduction in internal rotation is often the first sign<br />Age, obesity and previous joint problems are risk factors</td></tr><tr><td><b>Inflammatory arthritis</b></td><td>Pain in the morning<br />Systemic features<br />Raised inflammatory markers</td></tr><tr><td><b>Referred lumbar spine pain</b></td><td>Femoral nerve compression may cause referred pain in the hip<br />Femoral nerve stretch test may be positive - lie the patient prone. Extend the hip joint with a straight leg then bend the knee. This stretches the femoral nerve and will cause pain if it is trapped</td></tr><tr><td><b>Greater trochanteric pain syndrome (Trochanteric bursitis)</b></td><td>Due to repeated movement of the fibroelastic iliotibial band<br />Pain and tenderness over the lateral side of thigh<br />Most common in women aged 50-70 years</td></tr><tr><td><b>Meralgia paraesthetica</b></td><td>Caused by compression of lateral cutaneous nerve of thigh<br />Typically burning sensation over antero-lateral aspect of thigh</td></tr><tr><td><b>Avascular necrosis</b></td><td>Symptoms may be of gradual or sudden onset<br />May follow high dose steroid therapy or previous hip fracture of dislocation</td></tr><tr><td><b>Pubic symphysis dysfunction</b></td><td>Common in pregnancy<br />Ligament laxity increases in response to hormonal changes of pregnancy<br />Pain over the pubic symphysis with radiation to the groins and the medial aspects of the thighs. A waddling gait may be seen</td></tr><tr><td><b>Transient idiopathic osteoporosis</b></td><td>An uncommon condition sometimes seen in the third trimester of pregnancy<br />Groin pain associated with a limited range of movement in the hip<br />Patients may be unable to weight bear<br />ESR may be elevated</td></tr></tbody></table></div>",
        "notes_hash": "b0d467e1f8243eef08cb5bf38445a75a",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4687",
        "up_votes": "35",
        "down_votes": "19",
        "column_array": [
            0,
            "4239",
            "3973",
            "3316",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/iTfDvFCPZ_w\" data-description=\"Hip Examination\" data-upvotes=\"6\" data-downvotes=\"2\" data-media=\"136\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/iTfDvFCPZ_w/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/iTfDvFCPZ_w\" data-description=\"Hip Examination\" data-upvotes=\"6\" data-downvotes=\"2\" data-media=\"136\">Hip Examination</a></td></tr><tr><td><span ><small>Oxford Medical Education - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_241\" data-mediaid=\"241\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_241\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_241\" data-mediaid=\"241\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_241\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1544",
        "new_question_id": "9829",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "0",
        "notes_id_link": "1_678",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Primary herpes simplex infection",
            "Pityriasis rosea",
            "Polymorphic eruption of pregnancy",
            "Pemphigoid gestationis",
            "Pompholyx",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A woman who is 31 weeks pregnant presents with a rash on her abdomen and thighs:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><img class='ajaximage' src = 'https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddx021.jpg' /></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'></td></tr></table></CENTER><br />The rash is very itchy and she is having difficulty sleeping at night. What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "3",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Polymorphic eruption of pregnancy</b>. Polymorphic eruption of pregnancy (PEP), also known as pruritic urticarial papules and plaques of pregnancy (PUPPP), is a benign dermatological condition that occurs in late pregnancy. It typically presents with intensely itchy, polymorphic lesions including erythematous papules, vesicles or plaques. The rash often starts on the abdomen, particularly within stretch marks (striae), and can spread to the thighs and buttocks but rarely involves the face or mucous membranes. This presentation matches the patient's symptoms and her stage of pregnancy.<br /><br /><b>Primary herpes simplex infection</b> would typically present with painful grouped vesicles on an erythematous base, which may then ulcerate. Primary infections can be associated with systemic symptoms such as fever and malaise. Herpes simplex is not confined to late stages of pregnancy and does not specifically target areas with striae.<br /><br /><b>Pityriasis rosea</b> usually starts with a single 'herald patch', followed by a 'Christmas-tree' distribution of smaller patches along skin cleavage lines, predominantly on the trunk. It is not related to pregnancy nor does it preferentially affect areas with striae.<br /><br /><b>Pemphigoid gestationis</b>, previously known as herpes gestationis, is a rare autoimmune blistering disorder associated with pregnancy. It usually begins in the second or third trimester or immediately postpartum. Lesions often start around the umbilicus before spreading to other parts of the body but unlike PEP, pemphigoid gestationis frequently involves the palms, soles and mucous membranes.<br /><br />Lastly, <b>pompholyx</b>, also known as dyshidrotic eczema, primarily affects hands and feet causing itchy vesicles; therefore it wouldn't explain this patient's rash location.<br />",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A woman who is 31 weeks pregnant presents with a rash on her abdomen and thighs:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><img class='ajaximage' src = 'https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddx021.jpg' /></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'></td></tr></table></CENTER><br />The rash is very itchy and she is having difficulty sleeping at night. What is the most likely diagnosis?",
        "correct_answer": "3",
        "question_notes": "The correct answer is <b>Polymorphic eruption of pregnancy</b>. Polymorphic eruption of pregnancy (PEP), also known as pruritic urticarial papules and plaques of pregnancy (PUPPP), is a benign dermatological condition that occurs in late pregnancy. It typically presents with intensely itchy, polymorphic lesions including erythematous papules, vesicles or plaques. The rash often starts on the abdomen, particularly within stretch marks (striae), and can spread to the thighs and buttocks but rarely involves the face or mucous membranes. This presentation matches the patient's symptoms and her stage of pregnancy.<br /><br /><b>Primary herpes simplex infection</b> would typically present with painful grouped vesicles on an erythematous base, which may then ulcerate. Primary infections can be associated with systemic symptoms such as fever and malaise. Herpes simplex is not confined to late stages of pregnancy and does not specifically target areas with striae.<br /><br /><b>Pityriasis rosea</b> usually starts with a single 'herald patch', followed by a 'Christmas-tree' distribution of smaller patches along skin cleavage lines, predominantly on the trunk. It is not related to pregnancy nor does it preferentially affect areas with striae.<br /><br /><b>Pemphigoid gestationis</b>, previously known as herpes gestationis, is a rare autoimmune blistering disorder associated with pregnancy. It usually begins in the second or third trimester or immediately postpartum. Lesions often start around the umbilicus before spreading to other parts of the body but unlike PEP, pemphigoid gestationis frequently involves the palms, soles and mucous membranes.<br /><br />Lastly, <b>pompholyx</b>, also known as dyshidrotic eczema, primarily affects hands and feet causing itchy vesicles; therefore it wouldn't explain this patient's rash location.<br />",
        "answer_order": "3",
        "answer": "3",
        "title": "Skin disorders associated with pregnancy",
        "body": "Atopic eruption of pregnancy<br /><ul><li>is the <span class=\"concept\" data-cid=\"10472\">commonest skin disorder found in pregnancy</span></li><li>it typically presents as an eczematous, itchy red rash.</li><li>no specific treatment is needed</li></ul><br />Polymorphic eruption of pregnancy<br /><ul><li>pruritic condition associated with last trimester</li><li>lesions often first appear in abdominal striae</li><li>management depends on severity: emollients, mild potency topical steroids and oral steroids may be used</li></ul><br /><CENTER><table><tr><td align = 'left' colspan='2'><img class='ajaximage' src = 'https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddx021.jpg' /></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'></td></tr></table></CENTER><div class='imagetext'>Polymorphic eruption of pregnancy</div><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd022b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd022.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd022b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Polymorphic eruption of pregnancy</div><br /><CENTER><table><tr><td align = 'left' colspan='2'><img class='ajaximage' src = 'https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/img027.jpg' /></td></tr><tr><td valign='top' align='left'></td><td align='right'></td></tr></table></CENTER><div class='imagetext'>Polymorphic eruption of pregnancy</div><br />Pemphigoid gestationis<br /><ul><li>pruritic blistering lesions</li><li>often develop in peri-umbilical region, later spreading to the trunk, back, buttocks and arms</li><li>usually presents 2nd or 3rd trimester and is rarely seen in the first pregnancy</li><li>oral corticosteroids are usually required</li></ul><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd019b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd019.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd019b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Pemphigoid gestationis</div><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd020b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd020.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://www.dermnet.org.nz'  target='_blank' style = 'font-size:11px; color:LightGray;' >DermNet NZ</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ddd020b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Pemphigoid gestationis</div>",
        "notes_hash": "fe1305c052c980013d100b94a1ddecf2",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5850",
        "up_votes": "35",
        "down_votes": "10",
        "column_array": [
            0,
            "25",
            "113",
            "5003",
            "657",
            "52",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1081\" data-linkid=\"1081\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1081\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">12</span><button type=\"button\" style=\"\" id=\"link_dislike_1081\" data-linkid=\"1081\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1081\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.dermnetnz.org/topics/polymorphic-eruption-of-pregnancy/\">Polymorphic eruption of pregnancy</a></td></tr></table><br><br><table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1080\" data-linkid=\"1080\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1080\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"link_dislike_1080\" data-linkid=\"1080\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1080\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.dermnetnz.org/topics/pemphigoid-gestationis/\">Pemphigoid gestationis</a></td></tr></table>",
        "media": "",
        "comment_count": 3,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_2055",
        "new_question_id": "4158",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "0",
        "notes_id_link": "1_1699",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Oral ramipril",
            "IV hydralazine",
            "Lifestyle interventions",
            "Plan delivery of the foetus within 48 hours",
            "Admit for observation",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A nurse informs you of a 30-year-old woman who is 38 weeks pregnant. She says that the patient has a blood pressure reading of 155/90 mmHg. Her previous blood pressure 2 days ago was 152/85 mmHg. A 24-hour urine collection is requested which shows a urinary protein excretion of 0.7g / 24 hours. She was previously healthy prior to becoming pregnant. <br /><br />After giving her oral labetalol, what is the next line management in this situation?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "According to the current guidelines, pregnant women who have mild or moderate gestational hypertension, are more than 37 week pregnant, and are showing signs of pre-eclampsia, should be recommended to give birth within 24 - 48 hours. <br /><br />Source: http:www.nice.org.uk/guidance/cg107/evidence/cg107-hypertension-in-pregnancy-full-guideline3",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A nurse informs you of a 30-year-old woman who is 38 weeks pregnant. She says that the patient has a blood pressure reading of 155/90 mmHg. Her previous blood pressure 2 days ago was 152/85 mmHg. A 24-hour urine collection is requested which shows a urinary protein excretion of 0.7g / 24 hours. She was previously healthy prior to becoming pregnant. <br /><br />After giving her oral labetalol, what is the next line management in this situation?",
        "correct_answer": "4",
        "question_notes": "According to the current guidelines, pregnant women who have mild or moderate gestational hypertension, are more than 37 week pregnant, and are showing signs of pre-eclampsia, should be recommended to give birth within 24 - 48 hours. <br /><br />Source: http:www.nice.org.uk/guidance/cg107/evidence/cg107-hypertension-in-pregnancy-full-guideline3",
        "answer_order": "4",
        "answer": "4",
        "title": "Hypertension in pregnancy",
        "body": "It's useful to remember that in normal pregnancy:<br /><ul><li>blood pressure usually falls in the first trimester (particularly the diastolic), and continues to fall until 20-24 weeks</li><li>after this time the blood pressure usually increases to pre-pregnancy levels by term</li></ul><br />NICE published guidance in 2010 on the management of hypertension in pregnancy. They also made recommendations on reducing the risk of hypertensive disorders developing in the first place. Women who are at high risk of developing pre-eclampsia should take aspirin 75mg od from 12 weeks until the birth of the baby. <br /><br />Hypertension in pregnancy in usually defined as:<br /><ul><li>systolic > 140 mmHg or diastolic > 90 mmHg</li><li>or an increase above booking readings of > 30 mmHg systolic or > 15 mmHg diastolic</li></ul><br />After establishing that the patient is hypertensive they should be categorised into one of the following groups<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Pre-existing hypertension</b></th><th><b>Pregnancy-induced hypertension <br />(PIH, also known as gestational hypertension)</b></th><th><b>Pre-eclampsia</b></th></tr></thead><tbody><tr><td>A history of hypertension  before pregnancy or an elevated blood pressure > 140/90 mmHg before 20 weeks gestation<br /><br />No proteinuria, no oedema <br /><br />Occurs in 3-5% of pregnancies and is more common in older women<br /><br />If a pregnant woman takes an <span class=\"concept\" data-cid=\"11954\">ACE inhibitor or angiotensin II receptor blocker (ARB) for pre-existing hypertension this should be stopped immediately</span> and alternative antihypertensives started (e.g. labetalol) whilst awaiting specialist review<br /></td><td>Hypertension (as defined above) occurring in the second half of pregnancy (i.e. after 20 weeks)<br /><br />No proteinuria, no oedema <br /><br />Occurs in around 5-7% of pregnancies<br /><br />Resolves following birth (typically after one month). Women with PIH are at increased risk of future pre-eclampsia or hypertension later in life</td><td>Pregnancy-induced hypertension in association with proteinuria (> 0.3g / 24 hours)<br /><br />Oedema may occur but is now less commonly used as a criteria<br /><br />Occurs in around 5% of pregnancies</td></tr></tbody></table></div><br />Management<br /><ul><li>oral labetalol is now first-line following the 2010 NICE guidelines</li><li>oral nifedipine (e.g. if asthmatic) and hydralazine</li></ul>",
        "notes_hash": "e9168fa437e490997b3f92465e8fb2a5",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4857",
        "up_votes": "73",
        "down_votes": "107",
        "column_array": [
            0,
            "13",
            "205",
            "114",
            "2414",
            "2111",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Royal College of Physicians</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_619\" data-linkid=\"619\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_619\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">12</span><button type=\"button\" style=\"\" id=\"link_dislike_619\" data-linkid=\"619\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_619\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.rcpjournals.org/content/clinmedicine/13/1/57\">2013 Renal disease and hypertension in pregnancy</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_697\" data-linkid=\"697\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_697\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">12</span><button type=\"button\" style=\"\" id=\"link_dislike_697\" data-linkid=\"697\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_697\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng133/chapter/Recommendations\">2019 Hypertension in pregnancy: diagnosis and management</a></td></tr></table><br><br><table style='width:100%'><tr><td>New England Journal of Medicine</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1282\" data-linkid=\"1282\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1282\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">10</span><button type=\"button\" style=\"\" id=\"link_dislike_1282\" data-linkid=\"1282\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1282\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://dx.doi.org/10.1056/NEJMoa1704559\">Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia: Double-blinded RCT</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/a/a4/Preeclampsia_%26_eclampsia.webm\" data-description=\"Preeclampsia &amp; eclampsia\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"216\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/a/a4/Preeclampsia_%26_eclampsia.webm\" data-description=\"Preeclampsia &amp; eclampsia\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"216\">Preeclampsia &amp; eclampsia</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_485\" data-mediaid=\"485\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_485\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_485\" data-mediaid=\"485\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_485\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/yta5RRJ-Mg8\" data-description=\"Pre Eclampsia - Overview\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"354\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/yta5RRJ-Mg8/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/yta5RRJ-Mg8\" data-description=\"Pre Eclampsia - Overview\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"354\">Pre Eclampsia - Overview</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_600\" data-mediaid=\"600\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_600\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_600\" data-mediaid=\"600\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_600\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 7,
        "concepts_for_notes": {
            "11954": {
                "concept_text": "If a pregnant woman takes an ACE inhibitor or angiotensin II receptor blocker (ARB) for pre-existing hypertension this should be stopped immediately and alternative antihypertensives started (e.g. labetalol) whilst awaiting specialist review",
                "concept_percentile": "62"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "5650_B_389",
        "new_question_id": "32238",
        "question_type": "0",
        "category": "5",
        "concept_id_link": "11369",
        "notes_id_link": "1_616",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Ibuprofen",
            "Paroxetine",
            "Phlebotomy",
            "Ruxolitinib",
            "Splenectomy",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 60-year-old woman presents to her GP with whole-body itching which is worst after she has taken a bath, tingling and burning sensations in her hands and feet, and headaches. She has felt fatigued over the past year and a half, however, the symptoms of itching and tingling peripheries have only been present for the past 3 months. On examination, she is noted to have a palpable spleen which is 3cm below the costal angle. She has a full blood count which shows:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Hb</td><td>184 g/L</td><td>Female: (115 - 160)</td></tr><tr><td>Platelets</td><td>380 * 10<sup>9</sup>/L</td><td>(150 - 400)</td></tr><tr><td>WBC</td><td>9.0 * 10<sup>9</sup>/L</td><td>(4.0 - 11.0)</td></tr></tbody></table></div><br />What is the first-line management for this patient?",
            "",
            ""
        ],
        "answers": [
            "3",
            "0",
            "0"
        ],
        "notes": [
            "This patient is presenting with symptoms and signs consistent with polycythaemia vera:<br /><ul><li>Pruritis (worst after taking showers or hot baths).</li><li>Tingling, burning, and numbness in arms, hands, and feet.</li><li>Headaches and lethargy.</li><li>Splenomegaly.</li><li>Elevated haemoglobin on full blood count.</li></ul><br />Phlebotomy or venesection is performed to remove a patient's blood in order to reduce the haemoglobin levels in patients. Initially, patients may need this procedure every week; however when the condition is under control, most patients require venesection every 6 to 12 weeks. <br /><br />Ibuprofen is not a mainstay treatment for polycythaemia vera, however aspirin is used to reduce the clotting risk associated with the disease.<br /><br />Paroxetine has been used in multiple clinical trials in the management of polycythaemia vera induced pruritis. It is useful as adjuvant therapy for patients who continue to experience pruritis alongside polycythaemia, however, it should not be used in place of venesection which controls the haemoglobin (and will subsequently improve symptoms of pruritis). <br /><br />Ruxolitinib is a Janus kinase (JAK) 1 and 2 inhibitor which is used in the management of polycythaemia vera for prevention of thrombus formation. It is not a first-line management, and is used in patients who are resistant or intolerant to hydroxyurea. <br /><br />Splenectomy is not a mainstay management in patients with polycythaemia vera. While the spleen increases in size due to increased haemoglobin - with adequate management to maintain the patient's haemoglobin within the normal range, there is no need for splenectomy.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 60-year-old woman presents to her GP with whole-body itching which is worst after she has taken a bath, tingling and burning sensations in her hands and feet, and headaches. She has felt fatigued over the past year and a half, however, the symptoms of itching and tingling peripheries have only been present for the past 3 months. On examination, she is noted to have a palpable spleen which is 3cm below the costal angle. She has a full blood count which shows:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>Hb</td><td>184 g/L</td><td>Female: (115 - 160)</td></tr><tr><td>Platelets</td><td>380 * 10<sup>9</sup>/L</td><td>(150 - 400)</td></tr><tr><td>WBC</td><td>9.0 * 10<sup>9</sup>/L</td><td>(4.0 - 11.0)</td></tr></tbody></table></div><br />What is the first-line management for this patient?",
        "correct_answer": "3",
        "question_notes": "This patient is presenting with symptoms and signs consistent with polycythaemia vera:<br /><ul><li>Pruritis (worst after taking showers or hot baths).</li><li>Tingling, burning, and numbness in arms, hands, and feet.</li><li>Headaches and lethargy.</li><li>Splenomegaly.</li><li>Elevated haemoglobin on full blood count.</li></ul><br />Phlebotomy or venesection is performed to remove a patient's blood in order to reduce the haemoglobin levels in patients. Initially, patients may need this procedure every week; however when the condition is under control, most patients require venesection every 6 to 12 weeks. <br /><br />Ibuprofen is not a mainstay treatment for polycythaemia vera, however aspirin is used to reduce the clotting risk associated with the disease.<br /><br />Paroxetine has been used in multiple clinical trials in the management of polycythaemia vera induced pruritis. It is useful as adjuvant therapy for patients who continue to experience pruritis alongside polycythaemia, however, it should not be used in place of venesection which controls the haemoglobin (and will subsequently improve symptoms of pruritis). <br /><br />Ruxolitinib is a Janus kinase (JAK) 1 and 2 inhibitor which is used in the management of polycythaemia vera for prevention of thrombus formation. It is not a first-line management, and is used in patients who are resistant or intolerant to hydroxyurea. <br /><br />Splenectomy is not a mainstay management in patients with polycythaemia vera. While the spleen increases in size due to increased haemoglobin - with adequate management to maintain the patient's haemoglobin within the normal range, there is no need for splenectomy.",
        "answer_order": "3",
        "answer": "3",
        "title": "Polycythaemia vera: management",
        "body": "Polycythaemia vera is a myeloproliferative disorder caused by clonal proliferation of a marrow stem cell leading to an increase in red cell volume, often accompanied by overproduction of neutrophils and platelets. It has a peak incidence in the sixth decade, with typical features including hyperviscosity, pruritus and splenomegaly.<br /><br />Management<br /><ul><li><span class=\"concept\" data-cid=\"11368\">aspirin</span> <ul><li>reduces the risk of thrombotic events</li></ul></li><li><span class=\"concept\" data-cid=\"11369\">venesection</span><ul><li>first-line treatment to keep the haemoglobin in the normal range</li></ul></li><li>chemotherapy<ul><li>hydroxyurea - slight increased risk of secondary leukaemia</li><li>phosphorus-32 therapy</li></ul></li></ul><br />Prognosis<br /><ul><li><span class=\"concept\" data-cid=\"11367\">thrombotic events</span> are a significant cause of morbidity and mortality</li><li>5-15% of patients progress to myelofibrosis</li><li><span class=\"concept\" data-cid=\"778\">5-15% of patients progress to acute leukaemia</span> (risk increased with chemotherapy treatment)</li></ul>",
        "notes_hash": "f97c2301dbc80273d094675538c83159",
        "knowledge_graph_node_id_link": 1311,
        "concept": "Venesection is the first-line treatment in polycythaemia vera to keep the haemoglobin in normal range",
        "concept_percentile": "66",
        "concept_colour": "rgb(173,255,0)",
        "number_attempts": "4466",
        "up_votes": "30",
        "down_votes": "22",
        "column_array": [
            0,
            "134",
            "131",
            "3573",
            "365",
            "263",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>British Committee for Standards in Haematology</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1103\" data-linkid=\"1103\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1103\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"link_dislike_1103\" data-linkid=\"1103\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1103\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2005.05535.x/full\">2005 polycythaemia guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/jFxCZ91sDpI\" data-description=\"Polycythemia vera\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1030\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/jFxCZ91sDpI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/jFxCZ91sDpI\" data-description=\"Polycythemia vera\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1030\">Polycythemia vera</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1808\" data-mediaid=\"1808\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1808\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_1808\" data-mediaid=\"1808\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1808\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/vOPuAPCioE4\" data-description=\"What is polycythemia vera?\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"337\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/vOPuAPCioE4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/vOPuAPCioE4\" data-description=\"What is polycythemia vera?\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"337\">What is polycythemia vera?</a></td></tr><tr><td><span ><small>Khan Academy - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_573\" data-mediaid=\"573\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_573\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_573\" data-mediaid=\"573\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_573\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/BKAMEwKu1KM\" data-description=\"Polycythemia Vera\" data-upvotes=\"31\" data-downvotes=\"1\" data-media=\"743\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/BKAMEwKu1KM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/BKAMEwKu1KM\" data-description=\"Polycythemia Vera\" data-upvotes=\"31\" data-downvotes=\"1\" data-media=\"743\">Polycythemia Vera</a></td></tr><tr><td><span ><small>Medicosis Perfectionalis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1293\" data-mediaid=\"1293\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1293\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">31</span><button type=\"button\" style=\"\" id=\"media_dislike_1293\" data-mediaid=\"1293\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1293\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/PhvUku5Z_TU\" data-description=\"Polycythemia: Clinical Features, Management and Mnemonics\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"1397\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/PhvUku5Z_TU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/PhvUku5Z_TU\" data-description=\"Polycythemia: Clinical Features, Management and Mnemonics\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"1397\">Polycythemia: Clinical Features, Management and Mnemonics</a></td></tr><tr><td><span ><small>Townsend Teaching - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2462\" data-mediaid=\"2462\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2462\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2462\" data-mediaid=\"2462\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2462\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": {
            "11369": {
                "concept_text": "Venesection is the first-line treatment in polycythaemia vera to keep the haemoglobin in normal range",
                "concept_percentile": "66"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "7491_B_71",
        "new_question_id": "20327",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "9925",
        "notes_id_link": "1_1178",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Amiodarone 300mg and adrenaline 100mg",
            "Amiodarone 300mg and adrenaline 10mg",
            "Amiodarone 300mg and adrenaline 1mg",
            "Amiodarone 300mg and adrenaline 0.01g",
            "Lidocaine 1mg and adrenaline 10mg",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "An elderly patient on the oncology ward has a cardiac arrest. You start compressions and the resuscitation team are contacted. Assessment of the rhythm shows ventricular tachycardia (VT). Three cycles of CPR are performed and successive shocks given. <br /><br />After the third shock which two medications are indicated in the ALS protocol?",
            "",
            ""
        ],
        "answers": [
            "3",
            "0",
            "0"
        ],
        "notes": [
            "If identified in hospital these patients should be treated with a shock of a minimum of 150 joules (unless the defibrillator model states otherwise). Compressions at a rate of 30:2 should be restarted for 2 minutes and assessment of the rhythm again thereafter. If VF or pVT persists a second shock should be given. The previous steps should be repeated until the third shock where 1mg IV of adrenaline and 300mg IV of amiodarone should be given while still performing CPR. Afterwards, 1mg of adrenaline should be continued to be given after every other shock. The 2nd dose of amiodarone should be considered after a total of 5 defibrillation attempts.<br /><br />In circumstances where amiodarone is unavailable lidocaine can be used.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "An elderly patient on the oncology ward has a cardiac arrest. You start compressions and the resuscitation team are contacted. Assessment of the rhythm shows ventricular tachycardia (VT). Three cycles of CPR are performed and successive shocks given. <br /><br />After the third shock which two medications are indicated in the ALS protocol?",
        "correct_answer": "3",
        "question_notes": "If identified in hospital these patients should be treated with a shock of a minimum of 150 joules (unless the defibrillator model states otherwise). Compressions at a rate of 30:2 should be restarted for 2 minutes and assessment of the rhythm again thereafter. If VF or pVT persists a second shock should be given. The previous steps should be repeated until the third shock where 1mg IV of adrenaline and 300mg IV of amiodarone should be given while still performing CPR. Afterwards, 1mg of adrenaline should be continued to be given after every other shock. The 2nd dose of amiodarone should be considered after a total of 5 defibrillation attempts.<br /><br />In circumstances where amiodarone is unavailable lidocaine can be used.",
        "answer_order": "3",
        "answer": "3",
        "title": "Adult advanced life support",
        "body": "The following is based on the 2021 Resus Council guidelines. Please see the link for more details, below is only a very brief summary of key points.<br /><br />It should be remembered that the algorithm divides patients into those with:<br /><ul><li>'shockable' rhythms:  ventricular fibrillation/pulseless ventricular tachycardia (VF/pulseless VT)</li><li>'non-shockable' rhythms: asystole/pulseless-electrical activity (asystole/PEA)</li></ul><br />Major points include:<br /><ul><li>chest compressions<ul><li>the ratio of chest compressions to ventilation is <span class=\"concept\" data-cid=\"11516\">30:2</span></li><li>chest compressions are now continued while a defibrillator is charged</li></ul></li><li>defibrillation<ul><li><span class=\"concept\" data-cid=\"9130\">a single shock for VF/pulseless VT</span> followed by 2 minutes of CPR</li></ul></li><li>drug delivery<ul><li>IV access should be attempted and is first-line</li><li>if IV access cannot be achieved then drugs should be given via the <span class=\"concept\" data-cid=\"11515\">intraosseous route (IO)</span></li><li>delivery of drugs via a <span class=\"concept\" data-cid=\"11515\">tracheal tube is no longer recommended</span></li></ul></li><li>adrenaline<ul><li><span class=\"concept\" data-cid=\"8608\">adrenaline 1 mg as soon as possible for non-shockable rhythms</span></li><li>during a VF/VT cardiac arrest, <span class=\"concept\" data-cid=\"9925\">adrenaline 1 mg</span> is given once chest compressions have restarted after the third shock </li><li><span class=\"concept\" data-cid=\"11517\">repeat adrenaline 1mg every 3-5 minutes</span> whilst ALS continues</li></ul></li><li>amiodarone<ul><li><span class=\"concept\" data-cid=\"11518\">amiodarone 300 mg should be given to patients who are in VF/pulseless VT after 3 shocks</span> have been administered.</li><li><span class=\"concept\" data-cid=\"11519\">a further dose of amiodarone 150 mg should be given to patients who are in VF/pulseless VT after 5 shocks</span> have been administered</li><li><span class=\"concept\" data-cid=\"11520\">lidocaine</span> used as an alternative if amiodarone is not available or a local decision has been made to use lidocaine instead</li></ul></li><li><span class=\"concept\" data-cid=\"11521\">thrombolytic drugs</span><ul><li>should be considered if a pulmonary embolus  is suspected</li><li>if given, CPR should be continued for an extended period of <span class=\"concept\" data-cid=\"11522\">60-90 minutes</span></li></ul></li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd964b.png\" data-fancybox=\"gallery\" data-caption=\"\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd964.png\" alt=\"\" /></a></div></div></div><br />Other points<br /><ul><li><span class=\"concept\" data-cid=\"198\">atropine</span> is no longer recommended for routine use in asystole or pulseless electrical activity (PEA)</li><li>following successful resuscitation oxygen should be titrated to achieve saturations of 94-98%. This is to address the potential harm caused by hyperoxaemia</li></ul><br />Reversible causes of cardiac arrest:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>The 'Hs'</th><th>The 'Ts'</th></tr></thead><tbody><tr><td><ul><li>Hypoxia</li><li>Hypovolaemia</li><li>Hyperkalaemia, hypokalaemia, hypoglycaemia, hypocalcaemia, acidaemia and other metabolic disorders</li><li>Hypothermia</td><td></li><li>Thrombosis (coronary or pulmonary)</li><li><span class=\"concept\" data-cid=\"5831\">Tension pneumothorax</span></li><li>Tamponade - cardiac</li><li>Toxins</td></tr></tbody></table></div></li></ul>",
        "notes_hash": "01cd06e39a409427e046421edca879c8",
        "knowledge_graph_node_id_link": 11290,
        "concept": "The recommended dose of adrenaline to give during advanced ALS is 1mg",
        "concept_percentile": "42",
        "concept_colour": "rgb(255,214,0)",
        "number_attempts": "6312",
        "up_votes": "31",
        "down_votes": "7",
        "column_array": [
            0,
            "132",
            "465",
            "5548",
            "141",
            "26",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Resuscitation Council</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1018\" data-linkid=\"1018\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1018\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">67</span><button type=\"button\" style=\"\" id=\"link_dislike_1018\" data-linkid=\"1018\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1018\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">35</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.resus.org.uk/library/2021-resuscitation-guidelines/adult-advanced-life-support-guidelines\">2021 Advanced Life Support guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>Resuscitation Council</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_906\" data-linkid=\"906\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_906\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">42</span><button type=\"button\" style=\"\" id=\"link_dislike_906\" data-linkid=\"906\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_906\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">22</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.resus.org.uk/library/2021-resuscitation-guidelines/adult-basic-life-support-guidelines\">2021 Basic Life Support guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/jQYHQr3ebLo\" data-description=\"RC (UK) Cardiac Arrest Management Demo\" data-upvotes=\"51\" data-downvotes=\"5\" data-media=\"1181\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/jQYHQr3ebLo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/jQYHQr3ebLo\" data-description=\"RC (UK) Cardiac Arrest Management Demo\" data-upvotes=\"51\" data-downvotes=\"5\" data-media=\"1181\">RC (UK) Cardiac Arrest Management Demo</a></td></tr><tr><td><span ><small>Resuscitation Council (UK) - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2037\" data-mediaid=\"2037\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2037\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">51</span><button type=\"button\" style=\"\" id=\"media_dislike_2037\" data-mediaid=\"2037\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2037\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": {
            "8608": {
                "concept_text": "ALS - give adrenaline in non-shockable rhythm as soon as possible",
                "concept_percentile": "72"
            },
            "9130": {
                "concept_text": "VF/pulseless VT should be treated with 1 shock as soon as identified",
                "concept_percentile": "41"
            },
            "9925": {
                "concept_text": "The recommended dose of adrenaline to give during advanced ALS is 1mg",
                "concept_percentile": "42"
            },
            "11515": {
                "concept_text": "In ALS, if IV access cannot be achieved then drugs should be given via the intraosseous route (IO) - the tracheal route is no longer recommended",
                "concept_percentile": "30"
            },
            "11516": {
                "concept_text": "In ALS, the ratio of chest compressions to ventilation is 30:2",
                "concept_percentile": "28"
            },
            "11517": {
                "concept_text": "In ALS, once adrenaline has been initially given it should be repeated every 3-5 minutes whilst ALS continues",
                "concept_percentile": "53"
            },
            "11518": {
                "concept_text": "In ALS, amiodarone 300 mg should be given to patients who are in VF/pulseless VT after 3 shocks have been administered.",
                "concept_percentile": "44"
            },
            "11519": {
                "concept_text": "In ALS, a further dose of amiodarone 150 mg should be given to patients who are in VF/pulseless VT after 5 shocks have been administered",
                "concept_percentile": "48"
            },
            "11521": {
                "concept_text": "Thrombolytic drugs should be considered during CPR if a PE is suspected",
                "concept_percentile": "71"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_2101",
        "new_question_id": "2194",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "0",
        "notes_id_link": "1_1291",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Cervical trauma",
            "Inevitable miscarriage",
            "Placenta praevia",
            "Cervical neoplasia",
            "Placental abruption",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 30-year-old woman at 32 weeks gestation presents to the Emergency Department with a small amount of painless vaginal bleeding that came on spontaneously. Obstetric examination finds a cephalic presentation with high presenting part. The uterus is non-tender. The cervical os is closed and the cervix appears normal. Which of the following diagnoses is most likely?",
            "",
            ""
        ],
        "answers": [
            "3",
            "",
            ""
        ],
        "notes": [
            "Placenta praevia refers to a pathological positioning of the placenta in the lower segment of the uterus, either wholly or partly. If the placenta overlies the internal cervical os then this is classed as 'major praevia', whereas in 'minor' or 'partial' praevia it does not. Bleeding from the placenta can occur spontaneously, as a result of trauma, or at the onset of labour as the cervix opens.<br /><br />Guidelines issued by the Royal College of Obstetricians and Gynaecologists state that placenta praevia should be considered in all cases of vaginal bleeding occurring after 20 weeks gestation. Features that increase suspicion of this condition include painless bleeding, high presenting part and abnormal fetal lie. Definitive diagnosis generally requires ultrasound examination to identify the position of the placenta.<br />(RCOG Green-top Guideline No. 27)<br /><br />With respect to the above case, the absence of pain makes placental abruption very unlikely, and the normal appearance of the cervix indicates that cervical trauma, cervical neoplasm and inevitable miscarriage are not the cause.<br /><br />",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 30-year-old woman at 32 weeks gestation presents to the Emergency Department with a small amount of painless vaginal bleeding that came on spontaneously. Obstetric examination finds a cephalic presentation with high presenting part. The uterus is non-tender. The cervical os is closed and the cervix appears normal. Which of the following diagnoses is most likely?",
        "correct_answer": "3",
        "question_notes": "Placenta praevia refers to a pathological positioning of the placenta in the lower segment of the uterus, either wholly or partly. If the placenta overlies the internal cervical os then this is classed as 'major praevia', whereas in 'minor' or 'partial' praevia it does not. Bleeding from the placenta can occur spontaneously, as a result of trauma, or at the onset of labour as the cervix opens.<br /><br />Guidelines issued by the Royal College of Obstetricians and Gynaecologists state that placenta praevia should be considered in all cases of vaginal bleeding occurring after 20 weeks gestation. Features that increase suspicion of this condition include painless bleeding, high presenting part and abnormal fetal lie. Definitive diagnosis generally requires ultrasound examination to identify the position of the placenta.<br />(RCOG Green-top Guideline No. 27)<br /><br />With respect to the above case, the absence of pain makes placental abruption very unlikely, and the normal appearance of the cervix indicates that cervical trauma, cervical neoplasm and inevitable miscarriage are not the cause.<br /><br />",
        "answer_order": "3",
        "answer": "3",
        "title": "Placenta praevia",
        "body": "Placenta praevia describes a placenta lying wholly or partly in the lower uterine segment<br /><br />Epidemiology<br /><ul><li>5% will have low-lying placenta when scanned at 16-20 weeks gestation</li><li>incidence at delivery is only 0.5%, therefore most placentas rise away from the cervix</li></ul><br />Associated factors<br /><ul><li>multiparity</li><li>multiple pregnancy</li><li>embryos are more likely to implant on a lower segment scar from previous caesarean section</li></ul><br />Clinical features<br /><ul><li>shock in proportion to visible loss</li><li><span class=\"concept\" data-cid=\"11738\">no pain</span></li><li>uterus not tender</li><li>lie and presentation may be abnormal</li><li>fetal heart usually normal</li><li>coagulation problems rare</li><li>small bleeds before large</li></ul><br />Diagnosis<br /><ul><li><span class=\"concept\" data-cid=\"11760\">digital vaginal examination should not be performed</span> before an ultrasound as it may provoke a severe haemorrhage</li><li>placenta praevia is often picked up on the routine 20 week abdominal ultrasound</li><li>the RCOG recommend the use of <span class=\"concept\" data-cid=\"11759\">transvaginal ultrasound</span> as it improves the accuracy of placental localisation and is considered safe</li></ul><br />Classical grading<br /><ul><li>I - placenta reaches lower segment but not the internal os</li><li>II - placenta reaches internal os but doesn't cover it</li><li>III - placenta covers the internal os before dilation but not when dilated</li><li>IV ('major') - placenta completely covers the internal os</li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd989b.png\" data-fancybox=\"gallery\" data-caption=\"Diagram showing normal vs low-lying placenta vs placenta praevia\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd989.png\" alt=\"\" /></a></div></div></div>",
        "notes_hash": "38b0cf134c481c2d82c4c110ebffa7f9",
        "knowledge_graph_node_id_link": 1429,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6670",
        "up_votes": "24",
        "down_votes": "10",
        "column_array": [
            0,
            "538",
            "204",
            "5375",
            "126",
            "427",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Royal College of Obstetricians and Gynaecologists</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1248\" data-linkid=\"1248\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1248\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"link_dislike_1248\" data-linkid=\"1248\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1248\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.1111/1471-0528.15306\">2018 Placenta praevia guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/xnRIF8SDYf8\" data-description=\"Placenta previa\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"28\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/xnRIF8SDYf8/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/xnRIF8SDYf8\" data-description=\"Placenta previa\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"28\">Placenta previa</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_52\" data-mediaid=\"52\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_52\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_52\" data-mediaid=\"52\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_52\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 6,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "4224_B_113",
        "new_question_id": "25833",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "11222",
        "notes_id_link": "1_439",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Botox",
            "Dantrolene",
            "Diazepam",
            "Gabapentin",
            "Tizanidine",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 45-year-old woman with known multiple sclerosis for several years has been experiencing worsening muscle stiffness and difficulty in producing smooth movements. She has been taking baclofen for a year now but has had no effect.<br /><br />What is the next best medication to help with these symptoms?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "Spasticity in multiple sclerosis is a result of demyelination along the nerves of the brain and spinal cord that control movement. Sometimes the stiffness caused by spasticity is slight and can actually be helpful by giving individuals more support to stand or turn. Mild spasticity is not painful. However, when spasticity is more severe, it can become painful. The simplest and most effective treatment is exercises guided by physiotherapy. First-line medications include baclofen and gabapentin.<br /><br />Gabapentin is recommended as one of the first drugs to try in the treatment of spasms and spasticity by the NICE multiple sclerosis guideline. It is an anticonvulsant and used to treat neuropathic pain, but in higher doses can be effective against muscle spasms.<br /><br />Diazepam is a muscle relaxant that can reduce stiffness and spasms. Because of side effects at higher doses, it may be more useful at night. Diazepam is no longer widely used to treat multiple sclerosis spasms and stiffness but can help some people if other treatments have not worked.<br /><br />Botulinum toxin is a drug that is used to treat spasticity and spasms and bladder symptoms in multiple sclerosis. However, it is not used as first-line for spasticity and can be considered if conventional treatments prove ineffective.<br /><br />Dantrolene sodium is useful for spasticity it acts by decreasing muscle tone, clonus, and muscle spasm. However, it is not used as first-line and can be considered if conventional treatments prove ineffective.<br /><br />Tizanidine appears to reduce clinical spasticity and hyperreflexia in multiple sclerosis patients although no change in functional status was detected. Tizanidine may well serve as an alternate antispastic agent, alone or in combination with other agents.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 45-year-old woman with known multiple sclerosis for several years has been experiencing worsening muscle stiffness and difficulty in producing smooth movements. She has been taking baclofen for a year now but has had no effect.<br /><br />What is the next best medication to help with these symptoms?",
        "correct_answer": "4",
        "question_notes": "Spasticity in multiple sclerosis is a result of demyelination along the nerves of the brain and spinal cord that control movement. Sometimes the stiffness caused by spasticity is slight and can actually be helpful by giving individuals more support to stand or turn. Mild spasticity is not painful. However, when spasticity is more severe, it can become painful. The simplest and most effective treatment is exercises guided by physiotherapy. First-line medications include baclofen and gabapentin.<br /><br />Gabapentin is recommended as one of the first drugs to try in the treatment of spasms and spasticity by the NICE multiple sclerosis guideline. It is an anticonvulsant and used to treat neuropathic pain, but in higher doses can be effective against muscle spasms.<br /><br />Diazepam is a muscle relaxant that can reduce stiffness and spasms. Because of side effects at higher doses, it may be more useful at night. Diazepam is no longer widely used to treat multiple sclerosis spasms and stiffness but can help some people if other treatments have not worked.<br /><br />Botulinum toxin is a drug that is used to treat spasticity and spasms and bladder symptoms in multiple sclerosis. However, it is not used as first-line for spasticity and can be considered if conventional treatments prove ineffective.<br /><br />Dantrolene sodium is useful for spasticity it acts by decreasing muscle tone, clonus, and muscle spasm. However, it is not used as first-line and can be considered if conventional treatments prove ineffective.<br /><br />Tizanidine appears to reduce clinical spasticity and hyperreflexia in multiple sclerosis patients although no change in functional status was detected. Tizanidine may well serve as an alternate antispastic agent, alone or in combination with other agents.",
        "answer_order": "4",
        "answer": "4",
        "title": "Multiple sclerosis: management",
        "body": "Treatment in multiple sclerosis is focused on reducing the frequency and duration of relapses. There is no cure. <br /><br /><h5 class='notes-heading'>Acute relapse</h5><br /><span class=\"concept\" data-cid=\"10065\"> High-dose steroids (e.g. oral or IV methylprednisolone)</span> may be given for 5 days to shorten the length of an acute relapse. It should be noted that steroids shorten the duration of a relapse and do not alter the degree of recovery (i.e. whether a patient returns to baseline function)<br /><br /><h5 class='notes-heading'>Disease modifying drugs</h5><br />A number of drugs have been shown to reduce the risk of relapse in patients with MS. Typical indications for disease-modifying drugs include:<br /><ul><li>relapsing-remitting disease + 2 relapses in past 2 years + able to walk 100m unaided</li><li>secondary progressive disease + 2 relapses in past 2 years + able to walk 10m (aided or unaided)</li></ul><br />Drug options for reducing the risk of relapse in MS<br /><ul><li><span class=\"concept\" data-cid=\"11771\">natalizumab</span><ul><li>a recombinant monoclonal antibody that antagonises alpha-4 beta-1-integrin found on the surface of leucocytes</li><li>inhibit migration of leucocytes across the endothelium across the blood-brain barrier</li><li>generally considered to have the strongest evidence base for preventing relapse of the disease-modifying and hence is often used first-line</li><li>given intravenously</li></ul></li><li> <span class=\"concept\" data-cid=\"11862\">ocrelizumab</span><ul><li>humanized anti-CD20 monoclonal antibody</li><li>like natalizumab, it is considered a high-efficacy drug that is often used first-line</li><li>given intravenously</li></ul></li><li>fingolimod<ul><li>sphingosine 1-phosphate (S1P) receptor modulator</li><li>prevents lymphocytes from leaving lymph nodes</li><li>oral formulations are available</li></ul></li><li>beta-interferon <ul><li>not considered to be as effective as alternative disease-modifying drugs</li><li>given subcutaneously/intramuscularly</li></ul></li><li>glatiramer acetate<ul><li>immunomodulating drug - acts as an 'immune decoy'</li><li>given subcutaneously</li><li>along with beta-interferon considered an 'older drug' with less effectiveness compared to monoclonal antibodies and S1P) receptor modulators</li></ul></li></ul><br /><br /><h5 class='notes-heading'>Some specific problems</h5><br />Fatigue<br /><ul><li>once other problems (e.g. anaemia, thyroid or depression) have been excluded NICE recommend a trial of amantadine</li><li>other options include mindfulness training and CBT</li></ul><br />Spasticity<br /><ul><li><span class=\"concept\" data-cid=\"11222\">baclofen and gabapentin</span> are first-line. Other options include diazepam, dantrolene and tizanidine</li><li>physiotherapy is important</li><li>cannabis and botox are undergoing evaluation</li></ul><br />Bladder dysfunction<br /><ul><li>may take the form of urgency, incontinence, overflow etc</li><li>guidelines stress the importance of getting an <span class=\"concept\" data-cid=\"11221\">ultrasound</span> first to assess bladder emptying - anticholinergics may worsen symptoms in some patients</li><li>if significant residual volume &rarr; intermittent self-catheterisation</li><li>if no significant residual volume &rarr; anticholinergics may improve urinary frequency</li></ul><br />Oscillopsia (visual fields appear to oscillate)<br /><ul><li>gabapentin is first-line</li></ul>",
        "notes_hash": "0ed97d42bb988584137b2f2d595b561d",
        "knowledge_graph_node_id_link": 1076,
        "concept": "Baclofen and gabapentin are first-line for spasticity in multiple sclerosis",
        "concept_percentile": "90",
        "concept_colour": "rgb(50,255,0)",
        "number_attempts": "5500",
        "up_votes": "33",
        "down_votes": "58",
        "column_array": [
            0,
            "1162",
            "1749",
            "763",
            "1340",
            "486",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Multiple Sclerosis Society</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_826\" data-linkid=\"826\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_826\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"link_dislike_826\" data-linkid=\"826\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_826\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">19</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.pennine-gp-training.co.uk/res/MS%20guide%20for%20Primary%20Care.pdf\">Primary care guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1066\" data-linkid=\"1066\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1066\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">13</span><button type=\"button\" style=\"\" id=\"link_dislike_1066\" data-linkid=\"1066\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1066\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">7</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/cg186/chapter/1-Recommendations\">2014 Multiple Sclerosis guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ScaY3P2UOz8\" data-description=\"Multiple sclerosis\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"1470\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ScaY3P2UOz8/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ScaY3P2UOz8\" data-description=\"Multiple sclerosis\" data-upvotes=\"1\" data-downvotes=\"0\" data-media=\"1470\">Multiple sclerosis</a></td></tr><tr><td><span ><small>Rhesus Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2593\" data-mediaid=\"2593\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2593\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2593\" data-mediaid=\"2593\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2593\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/yzH8ul5PSZ8\" data-description=\"Multiple sclerosis - causes, symptoms, diagnosis, treatment, pathology\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"4\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/yzH8ul5PSZ8/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/yzH8ul5PSZ8\" data-description=\"Multiple sclerosis - causes, symptoms, diagnosis, treatment, pathology\" data-upvotes=\"3\" data-downvotes=\"1\" data-media=\"4\">Multiple sclerosis - causes, symptoms, diagnosis, treatment, pathology</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_9\" data-mediaid=\"9\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_9\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_9\" data-mediaid=\"9\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_9\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/KcZUPqobMgI\" data-description=\"Multiple sclerosis\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"671\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/KcZUPqobMgI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/KcZUPqobMgI\" data-description=\"Multiple sclerosis\" data-upvotes=\"1\" data-downvotes=\"1\" data-media=\"671\">Multiple sclerosis</a></td></tr><tr><td><span ><small>Soton Brain Hub - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1162\" data-mediaid=\"1162\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1162\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_1162\" data-mediaid=\"1162\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1162\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ReXMFCQALHM\" data-description=\"Multiple sclerosis\" data-upvotes=\"0\" data-downvotes=\"2\" data-media=\"102\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ReXMFCQALHM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ReXMFCQALHM\" data-description=\"Multiple sclerosis\" data-upvotes=\"0\" data-downvotes=\"2\" data-media=\"102\">Multiple sclerosis</a></td></tr><tr><td><span ><small>Podmedics - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_174\" data-mediaid=\"174\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_174\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_174\" data-mediaid=\"174\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_174\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "11222": {
                "concept_text": "Baclofen and gabapentin are first-line for spasticity in multiple sclerosis",
                "concept_percentile": "90"
            }
        },
        "optimisation_reason": ""
    }
]